Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...
12 Abril 2021 - 5:39PM
Edgar (US Regulatory)
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b)
OF THE SECURITIES EXCHANGE ACT OF 1934.
| |
|
Commission File Number
001-32839 |
|
| Issuer: | Avid Bioservices, Inc. |
| Exchange: | Nasdaq Stock Market LLC |
|
(Exact name of Issuer as specified in its charter, and name of
Exchange where security is listed and/or registered)
|
|
| Address: | 14282 Franklin Avenue
Tustin,
CALIFORNIA
92780 |
| Telephone number: | 7148380500 |
|
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
|
|
| 10.50% Series E Convertible Preferred Stock |
|
(Description of class of securities)
|
|
|
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
|
| o 17 CFR 240.12d2-2(a)(1) |
| x 17 CFR 240.12d2-2(a)(2) |
| o 17 CFR 240.12d2-2(a)(3) |
| o 17 CFR 240.12d2-2(a)(4) |
| o
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
1 |
| o
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
|
|
|
Pursuant to the requirements for the Securities Exchange Act of 1934,
Nasdaq Stock Market LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
|
|
| 2021-04-12 | By | O'Neil Blake | | Senior Specialist |
|
Date
| | Name | | Title |
|
| 1 |
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
Avid Bioservices (NASDAQ:CDMOP) Gráfico Histórico do Ativo De Jun 2024 até Jul 2024
Avid Bioservices (NASDAQ:CDMOP) Gráfico Histórico do Ativo De Jul 2023 até Jul 2024
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
Terça, 2 de Julho de 2024 (2 semanas atrás) • GlobeNewswire Inc. |
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024
Segunda, 1 de Julho de 2024 (2 semanas atrás) • GlobeNewswire Inc. |
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance
Quinta, 23 de Maio de 2024 (2 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices to Participate at Upcoming Investor Conferences
Terça, 7 de Maio de 2024 (2 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
Quarta, 24 de Abril de 2024 (3 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
Quarta, 20 de Março de 2024 (4 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
Quinta, 7 de Março de 2024 (4 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
Quarta, 6 de Março de 2024 (4 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
Quarta, 6 de Março de 2024 (4 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023
Quinta, 7 de Dezembro de 2023 (7 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
Quinta, 30 de Novembro de 2023 (8 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
Quarta, 8 de Novembro de 2023 (8 meses atrás) • GlobeNewswire Inc. |
Mais Notícias de Avid Bioservices, Inc.
Parece que você não está logado. Clique no botão abaixo para se logar e ver seu histórico recente.
|